Stocks · News reference

Tyra Biosciences shares are trading lower after the company announced initial results from SURF302, its Phase 2 study evaluating oral dabogratinib in patients with FGFR3-altered low-grade intermediate-risk non-muscle invasive bladder cancer.

Sep 9, 2026, 2:08 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 15, 2026, 9:33 AMRishabh Mishra
Stock Market Today: S&P 500, Dow and Nasdaq Futures Fall as Brent Hovers Near $107 and FOMC Commences Two-Day Meeting— MSTR, CRWD, BMM in Focus (UPDATED)
U.S. stock futures declined on Tuesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Monday's lower close.
BMM BTCUSD CRWD ELMT EQRLF
SEC EDGARSep 14, 2026, 11:12 PMSEC EDGAR
8-K filing — Tyra Biosciences, Inc. (TYRA)
Filed: 2026-09-15 AccNo: 0001193125-26-390951 Size: 561 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
TYRA
BenzingaSep 14, 2026, 4:09 PMAvi Kapoor
Crude Oil Jumps 3%; Corning Shares Move Lower
U.S. stocks fell Monday as tech slid; Nvidia may invest $10B in Anthropic’s IPO. Oil rose 3%, while gold, silver and copper declined.
CLLS ELMT GLW NVDA QCLS
BenzingaSep 14, 2026, 3:01 PMAvi Kapoor
Elmet Group, Rum Group, Tyra Biosciences And Other Big Stocks Moving Higher On Monday
Nasdaq fell 1%, while Elmet surged 50.6% on $450M DoD funding plans; Rum, SailPoint, Tyra and cybersecurity stocks also rallied.
ALLT BMM CRWD ELMT FTNT